Investing.com - Edwards Lifesciences (NYSE:EW) reported second quarter earnings that beat analysts' expectations on Thursday and revenue that topped forecasts.
The firm reported earnings per share of $0.64 on revenue of $1.38B. Analysts polled by Investing.com anticipated EPS of $0.5533 on revenue of $1.28B. .
Edwards Lifesciences shares gained 3.37% to trade at $115.50 in after-hours trade following the report.
For the year, Edwards Lifesciences shares are up 23%, outperforming the STOXX 600 which is up 16.24% year to date.
Edwards Lifesciences follows other major Healthcare sector earnings this month
On Wednesday, July 21, 2021, J&J reported second quarter EPS of $2.48 on revenue of $23.31B, compared to forecasts of EPS of $2.29 on revenue of $22.49B.
UnitedHealth earnings beat analyst's expectations on Thursday, July 15, 2021, with second quarter EPS of $4.7 on revenue of $71.32B. Investing.com analysts expected EPS of $4.43 on revenue of $69.51B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar